S. Rahbar

953 total citations
46 papers, 669 citations indexed

About

S. Rahbar is a scholar working on Genetics, Cell Biology and Physiology. According to data from OpenAlex, S. Rahbar has authored 46 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 18 papers in Cell Biology and 12 papers in Physiology. Recurrent topics in S. Rahbar's work include Hemoglobinopathies and Related Disorders (28 papers), Hemoglobin structure and function (18 papers) and Erythrocyte Function and Pathophysiology (11 papers). S. Rahbar is often cited by papers focused on Hemoglobinopathies and Related Disorders (28 papers), Hemoglobin structure and function (18 papers) and Erythrocyte Function and Pathophysiology (11 papers). S. Rahbar collaborates with scholars based in United States, Iran and United Kingdom. S. Rahbar's co-authors include H. Lehmann, G. Nozari, James L. Figarola, Sofia Loera, Stephen Scott, Deborah Charlesworth, P.A. Lorkin, S Tuchinda, R. Bruce Wallace and Yayesh Asmerom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

S. Rahbar

44 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Rahbar United States 13 310 195 180 151 133 46 669
M. Stallings United States 9 269 0.9× 146 0.7× 169 0.9× 35 0.2× 125 0.9× 20 504
M Rossi United States 9 69 0.2× 54 0.3× 97 0.5× 49 0.3× 384 2.9× 11 544
Helen M. Anderson United Kingdom 12 58 0.2× 52 0.3× 57 0.3× 35 0.2× 194 1.5× 20 587
Akira Hirono Japan 18 117 0.4× 94 0.5× 43 0.2× 94 0.6× 364 2.7× 49 992
Linda Forman United States 14 109 0.4× 120 0.6× 58 0.3× 26 0.2× 550 4.1× 23 882
J. Bakker Netherlands 12 77 0.2× 68 0.3× 144 0.8× 19 0.1× 91 0.7× 33 366
Jamshid Javid United States 14 226 0.7× 155 0.8× 255 1.4× 7 0.0× 186 1.4× 25 670
N. Arous France 18 430 1.4× 198 1.0× 343 1.9× 14 0.1× 208 1.6× 60 933
N Hobolth Denmark 14 50 0.2× 28 0.1× 46 0.3× 212 1.4× 114 0.9× 37 848
Beryl Westwood United States 17 78 0.3× 60 0.3× 181 1.0× 72 0.5× 509 3.8× 26 871

Countries citing papers authored by S. Rahbar

Since Specialization
Citations

This map shows the geographic impact of S. Rahbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Rahbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Rahbar more than expected).

Fields of papers citing papers by S. Rahbar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Rahbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Rahbar. The network helps show where S. Rahbar may publish in the future.

Co-authorship network of co-authors of S. Rahbar

This figure shows the co-authorship network connecting the top 25 collaborators of S. Rahbar. A scholar is included among the top collaborators of S. Rahbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Rahbar. S. Rahbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bhatwadekar, Ashay D., Josephine V. Glenn, James L. Figarola, et al.. (2008). A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. British Journal of Ophthalmology. 92(4). 545–547. 38 indexed citations
3.
Figarola, James L., Sofia Loera, Yehua Weng, et al.. (2008). LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia. 51(5). 882–891. 42 indexed citations
4.
Scott, Stephen, et al.. (2003). LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia. 46(8). 1140–1152. 81 indexed citations
6.
Nozari, G., et al.. (1995). Molecular Analyses of β-Thalassa in Iran. Hemoglobin. 19(6). 425–431. 29 indexed citations
7.
Nozari, G., et al.. (1993). Splice Junction [IVS-II-1 (G→C)] Thalassemia; A New Mutation Detected in an Iranian Patient. Hemoglobin. 17(3). 279–283. 1 indexed citations
8.
Rahbar, S. & G. Nozari. (1993). A Novel Initiation Codon Mutation (ATG→ATT) in a β-Thalassemia Patient. Hemoglobin. 17(6). 557–562. 5 indexed citations
9.
Rahbar, S., et al.. (1992). Association of HB Hope [β 136(H14)GLY→ASP] and α-THALASSEMIA-2 (3.7 KB Deletion) Causing Severe Microcytic Anemia. Hemoglobin. 16(5). 421–425. 10 indexed citations
10.
Rahbar, S. & Yayesh Asmerom. (1989). Rapid HPLC Techniques for Globin Chain Synthesis Studies. Hemoglobin. 13(5). 475–487. 20 indexed citations
11.
Rahbar, S., G. Nozari, Ram Chillar, & R. Bruce Wallace. (1988). Further Evidence for a Post-Translational Phenomenon in the Interaction of α-Thalassemia with Sickle Cell Trait. Hemoglobin. 12(1). 71–76. 5 indexed citations
12.
Nozari, G., S. Rahbar, & R. Bruce Wallace. (1988). Haplotype analysis of the human β-globin gene complex using multiple locus specific oligonucleotide probes. Analytical Biochemistry. 172(1). 180–184. 2 indexed citations
13.
Carr, Brian I., et al.. (1988). Carcinogenicity and haemoglobin synthesis induction by cytidine analogues. British Journal of Cancer. 57(4). 395–402. 43 indexed citations
14.
Perutz, M. F., G. Fermi, J. Fogg, & S. Rahbar. (1988). Indirect allosteric effects of a neutral mutation. Journal of Molecular Biology. 201(2). 459–461. 7 indexed citations
15.
Lalezari, I., S. Rahbar, Parviz Lalezari, G. Fermi, & M. F. Perutz. (1988). LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein.. Proceedings of the National Academy of Sciences. 85(16). 6117–6121. 33 indexed citations
16.
Rahbar, S., et al.. (1981). Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin. Blood. 58(4). 813–817. 10 indexed citations
17.
Rahbar, S., et al.. (1981). Glycosylated minor C, D, and E hemoglobins. Biochemical Medicine. 26(1). 121–125. 7 indexed citations
18.
Rahbar, S., et al.. (1978). Hemoglobin Osu-Christiansborg (beta52 (D3) Aspyield Asn) in an Iranian family.. PubMed. 2(2). 175–9. 5 indexed citations
19.
Rahbar, S., et al.. (1974). A SIMPLE RAPID PROCEDURE FOR HEMOGLOBIN ELECTROPHORESIS USING A DROP OF DRIED BLOOD ON FILTER PAPER. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Lorkin, P.A., et al.. (1970). Two Haemoglobins Q, α74 (EF3) and α75 (EF4) Aspartic Acid→Histidine. British Journal of Haematology. 19(1). 117–125. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026